Lynch Ryan

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

Crescent Biopharma, Inc. (CBIO)

Transaction date 16 Sep 2026

Planned sale

Price

161.30

Quantity 81,518 -29.8%

Value US$2,778,823

Comments Filing

Crescent Biopharma, Inc. (CBIO)

Transaction date 22 Jun 2026

Planned sale

Price

123.85

Quantity 34,264 +28.3%

Value US$2,270,395

Comments Filing

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2026-09-18	2026-09-16	Crescent Biopharma, Inc. (CBIO)	PlS Planned sale	81,518 -29.8% 161.30 US$2,778,823	81,518 -29.8%	161.30	US$2,778,823
2026-06-23	2026-06-22	Crescent Biopharma, Inc. (CBIO)	PlS Planned sale	34,264 +28.3% 123.85 US$2,270,395	34,264 +28.3%	123.85	US$2,270,395